INTRODUCTION
Congenital coronary artery fi stula (CAF) is an uncommon form of congenital heart disease, 1 although outfl ow tract obstruction is one of the underlying etiological factors of ventriculo-coronary connections in ventricular hypoplastic diseases, especially in the presence of an intact ventricular septum. 2 Angiographic studies have revealed that the incidence of CAF ranges from 0.3 to 0.8%. 3 However, most patients with such anomalies are asymptomatic, early treatment is recommended to prevent complications such as congestive heart failure, pulmonary hypertension, myocardial ischemia or infarction, fi stula rupture with cardiac tamponade, and infective endocarditis . 4, 5 The fi rst successful transcatheter closure of a coronary artery fistula was reported by Reidy et al. in 1983 using a detachable balloon. 6 
MATERIALS AND METHOD
We have collected the pediatric percutaneous closure databases from Children's Hospital of Chongqing Medical University, Chongqing, P. R. China, to identify all patients with CAF who underwent to percutaneous closure from September 2004 to April 2013. All cases that had percutaneous closure for CAF with 3 different devices were studied. Medical records from all clinical details, electrocardiograms, chest X-ray, percutaneous closure data, and pre & post occlusion echocardiography parameters were analyzed. Records and angiograms from the occlusion procedures were studied to characterize hemodynamics, CAF anatomy, percutaneous closure technique, devices placement, procedure complications and CAF occlusion.
RESULTS

Study Patients
Between September 2004 and April 2013, we prospectively collected data on 5 cases with all available clinical details, cardiac catheterization data and echocardiography parameters had reviewed. All of 5 cases underwent percutaneous closure of a CAF at our institution. Patients we assessed by a standard echocardiographic protocol; all patients underwent transthoracic echocardiography (TTE). Written and informed consent obtained from all patients' guardians before underwent percutaneous closure.
Out of the 5 cases, there were 3 females and 2 males. Their age ranged between 7 months to 10 years 10 months (average aged 4.13 year). Table 1 describes the clinical characteristics of these patients prior to intervention. The most frequent fi ndings were palpitation and continuous murmur, prior to intervention. Of all 5 patients who underwent percutaneous closure were congenital CAF with no any associated congenital anomalies.
Coronary artery fi stula characteristics
The hemodynamic and angiographic characteristics of CAF closed with 3 different devices are described in Table 2 . Of the 5 CAF in which 3 different devices: VSD occluder, PDA occluder & detachable Cook coil were deployed. In 3 cases, fi stulas were originating from right coronary artery (RCA) and in 2 cases from left coronary artery (LCA). Drainage sites included the right ventricle (RV) in 4 patients and right atrium in 1 case Table 2 . None case had found more than one orifi ce fi stula. Table 2 describes the fi stula details, device size and procedural data.
Procedure details
Percutaneous closure of a CAF is performed under general anesthesia. Patients are given heparin 100 IU/kg body weight intravenously during the femoral venous and arterial accesses. The procedure was performed under fl uoroscopy and transthoracic echocardiography (TTE) control. After obtaining the hemodynamic data; aortic root angiography and selective coronary angiography were performed to demonstrate the fi stulae anatomical structure, its drainage site, and identify distal coronary branches. CAF closure was attempted percutaneous occlusion in all the cases. VSD occluders were used in 2 cases, PDA occluders in 2 and Cook Coil in 1 case. Among the 5 patients, 4 approached the fi stula through the antegrade venous approach and closed the fi stula with VSD occluders & PDA occluders while only one through the retrograde arterial route and closed with Cook coil. Selective coronary angiography and aortic angiography was performed just after device deployment. Finally, the correct position was confi rmed and the devices were released. Embolization was achieved in all patients.
CAF occlusion with COOK Coil
Percutaneous closure was attempted by a retrograde approach via femoral artery access with a 5 French (Fr) sheath, and using a standard microcoil embolization technique as previously described. 7, 8 Angiographic views allowed adequate visualization of the fi stula (Figure-1a &b) in order to determine the appropriate site for device delivery, and the coil size required. A 5Fr 3.50 guide catheter (TERUMO Corp., Tokyo, Japan) was positioned at the left coronary ostium. The delivery catheter, a 2.6Fr 150 cm Excelsior 1018 (144181) microcatheter guide (TERUMO Corp., Tokyo, Japan), was advanced under fl uoroscopic guidance over a RADIFOCUS's guide wire (TERUMO Corp., Tokyo, Japan) directly to the distal coronary artery (LCX) in order to occlude the drainage orifi ce and minimize the risk of distal embolization. Hemodynamic parameters were assessed by use of microcatheter at the level of the fi stula. The microcatheter was then positioned in the proximal segment of the fi stula (vessel diameter at the point was 2.25 mm) and a single stainless-steel COOK microcoil (5x5 mm; COOK Sandet-6, Bjaeverskov DENMARK) was deployed and advanced by using a straight 0.038-inch guidewire ( Figure 1c ). Just after releasing the device, coronary angiography confi rmed successful occlusion of the fi stula with minimal residual fl ow from the fi stula ( Figure 1d ). Following the above procedures, coil was implanted. Coronary angiography was repeated to confi rm the quality of the occlusion, and heparin (100 U per kg) was given during the procedure. There were no ECG (Electrocardiography) changes noted; no procedural complications occurred and the patient was discharged on the following day. The patient subsequently reported that her earlier clinical symptoms had completely disappeared, and that his recovery had continued uneventfully. We have not found any recurrence on follow up.
CAF occlusion with PDA ocluder
During the operation, two sheaths were inserted from the right and left femoral arteries and a sheath was inserted from the right femoral vein. From the right and left femoral arteries, a 6Fr JR3.5 guiding catheter (TERUMO Corp., Tokyo, Japan) and a 5Fr pigtail catheter (TERUMO) were inserted separately into the origin of CAF. Selective right coronary angiography showed a tortuous and giant fi stula from the RCA to the RV, and the distal part of the CAF was enlarged markedly (Figure 2a) . A 260 cm 0.889 mm (0.035") exchange wire (TERUMO) and a 5Fr multipurpose catheter (TERUMO) were inserted along the 6Fr guiding catheter and passed through the CAF to the RV. Then, the wire was inserted into the RA. The exchange wire was pulled out from the femoral vein by a gooseneck snare (TERUMO), which was inserted from the femoral vein into the RA; then the circuit was established from the femoral artery to the femoral vein. An 8Fr delivery sheath (Lifetech Scientifi c Inc., China) was inserted into the RA from the femoral vein along the circuit and kissed with a multipurpose catheter in the RA. Further, the long sheath was inserted into the CAF slowly. After this, the dilator and multipurpose catheter were drawn out, but the exchange wire was kept in the CAF. A native 10/12 mm Patent Duct Arteriosus (PDA) occluder (Lifetech Scientifi c Inc., China) was inserted to the top of the long sheath for 1 st patient (4 th patient used 8/10 mm). The long sheath was pulled out slowly, and the occluder was extended at the end of the CAF. When the occluder was successfully deployed in position, the exchange wire was pulled out from the femoral vein, and the occluder successfully closed the CAF without residual shunt ( Figure 2B ). The patient had no complaints and the ECG was similar to the preoperative one during the 30-minute observation. The RA and RV were normal on Trans-thoracic echocardiography (TTE), and a 12-lead ECG 24 hr postprocedure was unchanged. The patient's heart murmur disappeared. One month, 3 months, 6 months and 12 months later, the above symptoms did not recur.
CAF occlusion with VSD Occluder
The percutaneous closure procedure had done same as PDA occluder approach but we have chosen VSD occluder according to coronary angiography (CAG), showed the fi stula was straight and tubular in shape (Figure 3a) . The 2 nd patient (RCA to RA) & 5 th patient (LCA to RV), VSD occluder had used 5 mm and 6 mm respectively. Occlusion has been done under fl uoroscopy control (Figure 3b & c) . Once the occluder deployed in position, CAG showed the occluder successful occlude CAF without residual shunt (Figure 3d-f) and the patients had no any complaints during 30 minutes observation. The TTE has not shown any abnormalities and ECG was normal, which might show myocardial infarction (MI). The patient's murmur has disappeared. There was no recurrence of the above symptoms on follow up. The guide wire, pigtail catheter, exchange wire, multipurpose catheter, and gooseneck snare were used from TERUMO Corp., Tokyo, Japan. At same time, VSD occluder and delivery sheath were used from Lifetech Scientifi c Inc., China. 
Follow up details
Electrocardiography (ECG) and chest X-ray and echocardiogram were performed 24 hours after procedure. Echocardiographic and angiographic control showed complete and permanent occlusion in the 5 patients. All patients who underwent successful CAF percutaneous closure were followed up clinically and by chest X-ray, ECG and echocardiogram at 1, 3, 6 and 12 months in the fi rst year and annually thereafter. On follow-up, none of our patients showed recurrence the above symptoms, recanalization of the fi stula with recurrence of shunt, embolization of normal coronary branches, migration of closure devices to the cardiac chambers or great arteries, device fracture, or rupture of the fi stula itself. No death occurred during procedure and post closure.
DISCUSSION
Congenital coronary artery fi stula (CAF) is an uncommon form of congenital heart disease and rarely spontaneous closure of the fi stula may occur. 6 Although most patients with CAF are asymptomatic but according to our collected data, our patients had the following manifestations: palpitation, dyspnea and continuous murmur. Transthoracic echocardiography (TTE) and Doppler can diagnose coronary artery fi stulae and their drainage sites. 9 However, Trans-esophageal Echocardiograph (TEE) can identify the precise location of drainage site to aid in planning surgery. 10 Sometimes, angiography may fail to show the drainage site while TEE would be successful. 9, 11 Recently, some authors have recommended the TEE for the diagnosis of fistulas because of its better resolution. 12 During surgical management, Intra-operative TEE is useful for (a) localization of drainage site, (b) identify feeding vessels, (c) document abolition of fl ow (all without need for cardiopulmonary bypass) and (d) continuous monitoring of ventricular function to detect ischemic effects of ligation. 13 But in our center, we preferred TTE and Doppler for the diagnosis of congenital CAF. Patients with CAF are having complications such as congestive heart failure, fi stula rupture; infective endocarditis, myocardial infarction, aneurysm formation, and death are consequences that can be prevented by early diagnosis. A comprehensive review of congenital CAF in children led to the recommendation of early ligation of these fi stulas because of the high incidence of infectious and ischemic complications. 14 Management of congenital CAF is still controversial due to the variability of CAF clinical and angiography fi ndings with hemodynamic changes. Sometimes small lesions are managed conservatively because small and hemodynamically inconsequential CAFs generally run a benign long-term course and some of them close spontaneously. 15 It is generally recommended that the lesions should be closed, if patients are having symptoms such as dyspnea, cough and palpitation. There are two treatment options available: percutaneous closure and surgical closure of congenital CAF. Some authors reported that surgical treatment is very effective and safe. 5, [16] [17] [18] The fi rst successful surgical closure was reported by Biorck et al. 19 After that there have been many series published up to 56 cases. Overall, mortality is low (~1%); single ligation is common; excision of fi stula is rare; and cardiopulmonary bypass is used in approximately one-half of the cases. 20, 21 Reported complications are rare and include arrhythmias, myocardial infarctions, stroke, and ST-/T-wave changes on the electrocardiogram. Approximately a 10% rate of incomplete closure or recurrence of fi stulae is reported in the surgical literature. 22 However, in the Cheung et al., 2001 series of 41 patients, 21 agreed to undergo followup cardiac catheterization. 22 Among the 21, 4 (19%) had residual or recurrent fi stulae. They noted that the incidence of recurrence was higher in patients who underwent external plication versus those who had intracardiac closure.
Percutaneous closure of CAF is an alternative to surgical closure. The fi rst successful transcatheter closure of a coronary artery fi stula was reported by Reidy et al. 20 using a detachable balloon. The advantages of the transcatheter closure of CAFs are: shorter hospital stays, less myocardial damage, less invasion, and fewer complications compared with conventional open surgery possible for the patients. Successful occlusion of the CAFs at catheterization was reported in >83-95% of patients. In the remaining patients, they are to be managed conservatively or with surgery. 23 Percutaneous CAF closure is reported to yield a high degree of procedural success with low risk of serious complications. 7 During percutaneous closure of CAF, multiple devices have been used including coils, detachable balloons, covered stents, vascular plugs, atrial septal defect occluder, VSD occluder and PDA occluder. Over the years, there have been a series of transcatheter closure studies in up to 33 patients. Armsby and colleagues reported short-term fi ndings in 33 patients who underwent transcatheter closure. 8 Follow-up echocardiograms (median: 2.8 years) were obtained in 27 patients. There was no fl ow in 22 patients and 5 had small residual shunts. None had follow-up angiograms. Recently, Zhu et al. 24 reported transcatheter closure results of 24 patients. All had clinical follow-up ranging from 3 months to 10 years. No follow-up angiogram was obtained. One patient had a still murmur on examination at 6-month follow-up and subsequent echocardiography revealed residual fl ow. Not all the CAFs are suitable for percutaneous closure.
Mavroudis et al. 25 outlined the requirements for satisfactory embolization of a CAF as follows: (a) the ability to cannulate safely the branch coronary artery that supplies the fi stula (b) absence of large branch vessels that can be inadvertently embolized (c) the presence of single, narrow restrictive drainage site into the cardiac chamber or vessel, and (d) the absence of multiple fi stulous communications.
Using these criteria, the authors concluded that coil embolization was possible in only 37% of the fi stulas. There are two approaches for percutaneous closure; venous approach and arterial approach. Arterial approach is more suitable for small fi stulae that can be closed with coils. While the fi stula is large requiring large a device or a plug to close, the venous approach is suitable. Trehan et al. 4 approached the fi stula through the venous approach and closed them with AmplatzerTM devices and while using coils, they went through the arterial route.
The outcome of transcatheter occlusion is as good as that of surgical correction. Patients that are closed by using transcatheter techniques need to be closely followed up for complications such as residual shunts, formation of thrombus, new fi stula formation, coronary aneurysma and coronary artery stenosis. Clinical experiences show that the short-, middle-and long-term outcome of transcatheter closure of CAFs has been satisfactory. Residual or recurrent shunts after transcatheter closure have been reported in 10-20% of patients and these may require further procedures to achieve complete occlusion. 24, 26 A study shows that an incidence of major complications which occurs late after closure of CAFs with transcatheter and surgical interventions is 15%, reported by Valente et al. 27 Mortality related to surgical closure or transcatheter closure of isolated CAFs is low (<1%) 20, 28 In our study, CAF closure was attempted percutaneous occlusion in all the 5 cases & used three different devices; VAD occluder, PDA Occluder and detachable Cook coil to close the lesions. Among 5 patients, we approached percutaneous CAF closure though venous approach in 4 cases with and only one through arterial approach. The venous approach fistulae were closed with VSD occluder (2) and PDA occluder (2) but the only one arterial approach fi stula closed with Cook coil. Just after the device deployment, coronary and aortic angiography performed. At last, the correct position has confi rmed and the devices released. Embolization was achieved in all our 5 patients. After, percutaneous closure of CAF, all 5 patients have received heparin 50 IU/kg body weight 12 hourly for 3 days in our inpatient department and prescribed aspirin 3~5 mg/kg body weight for 6 months on discharge. There were no any major complications have found. No death occurred during and after closure.
CONCLUSION
According to our results and those of previously reported, we are able to say that Percutaneous closer of CAF is very safe and effective. The most of coronary artery fi stulae can be closed with percutaneous closure. However, the technique has minimal complications, shorter hospital stay, low morbidity and mortality. But the percutaneous approach is a fairly complicated intervention and requires an experienced operator and interventional specialist with expertise in both coronary arteriography and embolization techniques. In our hospital, there were such specialists who could perform percutaneous embolization.
